Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2007 | 01-2007 | 10-2006 | 07-2006 | 04-2006 | |
| Sales | 349,300 | 297,200 | 257,400 | 343,600 | 358,100 |
| Cost of Goods | 228,900 | 202,300 | 171,200 | 231,400 | 236,400 |
| Gross Profit | 120,400 | 94,900 | 86,200 | 112,200 | 121,700 |
| Operating Expenses | 86,900 | 88,000 | 88,000 | 88,600 | 96,900 |
| Operating Income | 34,400 | 7,200 | -1,600 | 24,000 | 25,200 |
| Other Income | 61,700 | 3,600 | 3,200 | 2,300 | 2,500 |
| Pre-tax Income | 96,100 | 10,800 | 1,600 | 26,300 | 27,700 |
| Income Tax | 2,700 | 1,100 | -44,700 | 3,100 | 2,600 |
| Net Income Continuous | 93,400 | 9,700 | 46,300 | 23,200 | 25,100 |
| Net Income Discontinuous | -1,300 | -6,100 | -6,200 | -18,600 | -2,300 |
| Net Income | $92,100 | $3,600 | $40,100 | $4,600 | $22,800 |
| EPS Basic Total Ops | 0.79 | 0.03 | 0.35 | 0.04 | 0.19 |
| EPS Basic Continuous Ops | 0.80 | 0.08 | 0.40 | 0.20 | 0.21 |
| EPS Basic Discontinuous Ops | -0.01 | -0.05 | -0.06 | -0.16 | -0.02 |
| EPS Diluted Total Ops | 0.72 | 0.03 | 0.35 | 0.04 | 0.19 |
| EPS Diluted Continuous Ops | 0.73 | 0.08 | 0.39 | 0.20 | 0.21 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.05 | -0.05 | -0.16 | -0.02 |
| EBITDA(a) | $51,500 | $-28,200 | $33,600 | $74,300 | $42,300 |